The meeting devoted to the project on the Strategy of the System of the Common Distribution Development in the Republic of Kazakhstan as well as discussion of the current issues of delivery and pricing of the pharmaceutical products, the healthcare products and cooperation with the national manufactures with the participation of the representatives of the national manufacturers of pharmaceutical production, the specialized associations and NCE “Atameken” was held today chaired by the Chairman of the Executive Board of LLP “SK-Pharmacy” Alibayev N.N.

We recall that one of the biggest world consulting companies of Big Four – “KPMG” – has signed an agreement with LLP “SK-Pharmacy” on full review of the current system of the Common Distribution with the aim of its improvement.

The state through the Common distributor makes its best to support the Kazakh manufacturers. The long-term contracts for 7-10 years are conducted, the preferences in the bid processes are provided.

Moreover, the Common distributor urged the national suppliers to increase the share of the Kazakh content.